Abstract
The G protein-coupled receptors (GPCRs) form one of the largest membrane receptor families. The nature of the ligands that interact with these receptors is highly diverse; they include light, peptides and hormones, neurotransmitters, and small molecular weight compounds. The GPCRs are involved in a wide variety of physiological processes and thus hold considerable therapeutic potential.
GPCR function is usually determined in cell-based assays, whose complexity nonetheless limits their use. The use of alternative, cell-free assays is hampered by the difficulties in purifying these seven-transmembrane domain receptors without altering their functional properties. Several methods have been proposed to immobilize GPCR on biosensor surfaces which use antibodies or avidin-/biotin-based capture procedures, alone or with reconstitution of the GPCR physiological microenvironment. Here we propose a method for GPCR immobilization in their native membrane microenvironment that requires no manipulation of the target receptor and maintains the many conformations GPCR can adopt in the cell membrane.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rich RL, Myszka DG (2007) Higher-throughput, label-free, real-time molecular interaction analysis. Anal Biochem 361:1–6
Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63:1256–1272
Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, Mortrud MT et al (2003) The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci U S A 100:4903–4908
Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5:993–996
Wise A, Gearing K, Rees S (2002) Target validation of G-protein coupled receptors. Drug Discov Today 7:235–246
Chini B, Parenti M (2004) G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J Mol Endocrinol 32:325–338
Drake MT, Shenoy SK, Lefkowitz RJ (2006) Trafficking of G protein-coupled receptors. Circ Res 99:570–582
Tan CM, Brady AE, Nickols HH, Wang Q, Limbird LE (2004) Membrane trafficking of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 44:559–609
Alves ID, Park CK, Hruby VJ (2005) Plasmon resonance methods in GPCR signaling and other membrane events. Curr Protein Pept Sci 6:293–312
Wink T, van Zuilen SJ, Bult A, van Bennkom WP (1997) Self-assembled monolayers for biosensors. Analyst 122:43R–50R
Fruh V, IJzerman AP, Siegal G (2011) How to catch a membrane protein in action: a review of functional membrane protein immobilization strategies and their applications. Chem Rev 111:640–656
O’Shannessy DJ, Brigham-Burke M, Peck K (1992) Immobilization chemistries suitable for use in the BIAcore surface plasmon resonance detector. Anal Biochem 205:132–136
Stein T, Gerisch G (1996) Oriented binding of a lipid-anchored cell adhesion protein onto a biosensor surface using hydrophobic immobilization and photoactive crosslinking. Anal Biochem 237:252–259
Gottschalk I, Lagerquist C, Zuo SS, Lundqvist A, Lundahl P (2002) Immobilized-biomembrane affinity chromatography for binding studies of membrane proteins. J Chromatogr B Analyt Technol Biomed Life Sci 768:31–40
Civjan NR, Bayburt TH, Schuler MA, Sligar SG (2003) Direct solubilization of heterologously expressed membrane proteins by incorporation into nanoscale lipid bilayers. Biotechniques 35:556–563
Charvolin D, Perez JB, Rouviere F, Giusti F, Bazzacco P, Abdine A et al (2009) The use of amphipols as universal molecular adapters to immobilize membrane proteins onto solid supports. Proc Natl Acad Sci U S A 106:405–410
Harding PJ, Hadingham TC, McDonnell JM, Watts A (2006) Direct analysis of a GPCR-agonist interaction by surface plasmon resonance. Eur Biophys J 35:709–712
Neumann L, Wohland T, Whelan RJ, Zare RN, Kobilka BK (2002) Functional immobilization of a ligand-activated G-protein-coupled receptor. Chembiochem 3:993–998
Karlsson OP, Lofas S (2002) Flow-mediated on-surface reconstitution of G-protein coupled receptors for applications in surface plasmon resonance biosensors. Anal Biochem 300:132–138
Navratilova I, Dioszegi M, Myszka DG (2006) Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology. Anal Biochem 355:132–139
Navratilova I, Sodroski J, Myszka DG (2005) Solubilization, stabilization, and purification of chemokine receptors using biosensor technology. Anal Biochem 339:271–281
Stenlund P, Babcock GJ, Sodroski J, Myszka DG (2003) Capture and reconstitution of G protein-coupled receptors on a biosensor surface. Anal Biochem 316:243–250
Salamon Z, Wang Y, Brown MF, Macleod HA, Tollin G (1994) Conformational changes in rhodopsin probed by surface plasmon resonance spectroscopy. Biochemistry 33:13706–13711
Munoz LM, Holgado BL, Martinez AC, Rodriguez-Frade JM, Mellado M (2012) Chemokine receptor oligomerization: a further step toward chemokine function. Immunol Lett 145:23–29
Thelen M, Munoz LM, Rodriguez-Frade JM, Mellado M (2010) Chemokine receptor oligomerization: functional considerations. Curr Opin Pharmacol 10:38–43
Fallahi-Sichani M, Linderman JJ (2009) Lipid raft-mediated regulation of G-protein coupled receptor signaling by ligands which influence receptor dimerization: a computational study. PLoS One 4:e6604
Ostrom RS, Insel PA (2004) The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol 143:235–245
Xu W, Yoon SI, Huang P, Wang Y, Chen C, Chong PL et al (2006) Localization of the kappa opioid receptor in lipid rafts. J Pharmacol Exp Ther 317:1295–1306
Yoshiura C, Kofuku Y, Ueda T, Mase Y, Yokogawa M, Osawa M et al (2010) NMR analyses of the interaction between CCR5 and its ligand using functional reconstitution of CCR5 in lipid bilayers. J Am Chem Soc 132:6768–6777
Hoffman TL, Canziani G, Jia L, Rucker J, Doms RW (2000) A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors. Proc Natl Acad Sci U S A 97:11215–11220
Weiss RA (1987) Retroviruses and human disease. J Clin Pathol 40:1064–1069
Verma IM, Somia N (1997) Gene therapy – promises, problems and prospects. Nature 389:239–242
Balliet JW, Bates P (1998) Efficient infection mediated by viral receptors incorporated into retroviral particles. J Virol 72:671–676
Walther W, Stein U (2000) Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs 60:249–271
Lewis PF, Emerman M (1994) Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68:510–516
Matrai J, Chuah MK, VandenDriessche T (2010) Recent advances in lentiviral vector development and applications. Mol Ther 18:477–490
Vogt VM, Simon MN (1999) Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy. J Virol 73:7050–7055
Akkina RK, Walton RM, Chen ML, Li QX, Planelles V, Chen IS (1996) High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J Virol 70:2581–2585
Bartz SR, Rogel ME, Emerman M (1996) Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J Virol 70:2324–2331
Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH et al (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263–267
Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15:871–875
Sachdeva G, D’Costa J, Cho JE, Kachapati K, Choudhry V, Arya SK (2007) Chimeric HIV-1 and HIV-2 lentiviral vectors with added safety insurance. J Med Virol 79:118–126
Gruber A, Kan-Mitchell J, Kuhen KL, Mukai T, Wong-Staal F (2000) Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. Blood 96:1327–1333
Amado RG, Chen IS (1999) Lentiviral vectors–the promise of gene therapy within reach? Science 285:674–676
Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D et al (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463–8471
Nguyen DH, Taub DD (2003) Inhibition of chemokine receptor function by membrane cholesterol oxidation. Exp Cell Res 291:36–45
Zhang J, Pekosz A, Lamb RA (2000) Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol 4:4634–4644
Vega B, Calle A, Sanchez A, Lechuga LM, Ortiz AM, Armelles G et al (2013) Real-time detection of the chemokine CXCL12 in urine samples by surface plasmon resonance. Talanta 109:209–215
Vega B, Munoz LM, Holgado BL, Lucas P, Rodriguez-Frade JM, Calle A et al (2011) Technical advance: surface plasmon resonance-based analysis of CXCL12 binding using immobilized lentiviral particles. J Leukoc Biol 90:399–408
Barroso R, Martinez Munoz L, Barrondo S, Vega B, Holgado BL, Lucas P et al (2012) EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5. FASEB J 26:4841–4854
Gasmi M, Glynn J, Jin MJ, Jolly DJ, Yee JK, Chen ST (1999) Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors. J Virol 73:1828–1834
Naldini L, Blomer U, Gage FH, Trono D, Verma IM (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 93:11382–11388
Frade JM, Mellado M, del Real G, Gutierrez-Ramos JC, Lind P, Martinez-A C (1997) Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. J Immunol 159:5576–5584
D’Hautcourt JL (2002) Quantitative flow cytometric analysis of membrane antigen expression. In: Robinson JP (ed) Current protocols in cytometry. Wiley, New York, Chapter 6: Unit 6 12
Mellado M, Kremer L, Manes S, Martinez-A C, Rodriguez-Frade JM (1997) Characterization of antigen-antibody and ligand-receptor interactions. In: Lefkovits I (ed) Immunology methods manual: . Academic, London, pp 1145–1162
Briggs JA, Wilk T, Welker R, Krausslich HG, Fuller SD (2003) Structural organization of authentic, mature HIV-1 virions and cores. EMBO J 22:1707–1715
Mauriz E, Calle A, Abad A, Montoya A, Hildebrandt A, Barcelo D et al (2006) Determination of carbaryl in natural water samples by a surface plasmon resonance flow-through immunosensor. Biosens Bioelectron 21:2129–2136
Mauriz E, Calle A, Montoya A, Lechuga LM (2006) Determination of environmental organic pollutants with a portable optical immunosensor. Talanta 69:359–364
Scherr M, Battmer K, Blomer U, Ganser A, Grez M (2001) Quantitative determination of lentiviral vector particle numbers by real-time PCR. Biotechniques 31:520–524
Acknowledgments
We thank the people at the Chemokine SIgnaling Group for much of the work that contributed to this review, especially Beatriz Vega, Pilar Lucas, and Jorge Villaverde, and to C. Bastos and C. Mark for the secretarial and editorial assistance, respectively. This work was supported in part by grants from the Spanish Ministry of Science and Innovation (SAF 2011-27370), the RETICS Program (RD12/0009/009; RIER), and the Madrid regional government (S2010/BMD-2350; RAPHYME).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Martínez-Muñoz, L., Barroso, R., Paredes, A.G., Mellado, M., Rodríguez-Frade, J.M. (2015). Methods to Immobilize GPCR on the Surface of SPR Sensors. In: Prazeres, D.M.F., Martins, S.A.M. (eds) G Protein-Coupled Receptor Screening Assays. Methods in Molecular Biology, vol 1272. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-2336-6_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2336-6_12
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-2335-9
Online ISBN: 978-1-4939-2336-6
eBook Packages: Springer Protocols